无水的
水合物
选择(遗传算法)
熔点
固态
化学
组合化学
材料科学
结晶学
立体化学
有机化学
物理化学
计算机科学
人工智能
作者
Okky Dwichandra Putra,Jenny Ottosson,Sten O. Nilsson Lill,Anna Pettersen
标识
DOI:10.1021/acs.cgd.1c01124
摘要
AZD9567 is a novel oral selective glucocorticoid receptor modulator drug candidate in AstraZeneca’s pipeline. Three distinctive solid forms of AZD9567 were identified during early development where Form A was found to be a hydrate, and both Forms B and C are anhydrous. In this study, we present the significance of applying crystal structure assessments along with typical solid-state experimental characterizations in early stage drug development to guide solid form selection. The Form A hydrate, which is usually regarded as the preferred form in liquid formulation, is found not stable, narrowing the form selection toward Forms B and C. Anhydrous Form C has disorder depending on the temperature and is more stable than anhydrous Form B, and this is supported by a higher melting point and experimental density as well as a series of density functional theory calculations. This eventually results in the recommendation of selecting anhydrous AZD9567 Form C as the solid form to move forward for further development.
科研通智能强力驱动
Strongly Powered by AbleSci AI